![Donald Wuchterl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Wuchterl
Director/Board Member at
ABEONA THERAPEUTICS INC.
Net worth: 970 664 $ as of 31/05/2026
Profile
Donald A. Wuchterl currently works at Abeona Therapeutics, Inc., as Independent Director from 2021.
Mr. Wuchterl also formerly worked at Astellas Gene Therapies, Inc., as Senior VP-Technical Operations & Quality from 2016 to 2021, Cytovance Biologics, Inc., as Chief Operating Officer & Senior Vice President from 2012 to 2016, and T-Knife Therapeutics, Inc., as Senior VP & Chief Manufacturing Officer from 2021 to 2022.
Mr. Wuchterl received his undergraduate degree from Colorado Technical University, Inc. and Masters Business Admin degree from Fitchburg State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/04/2026 | 167,935 ( 0.29% ) | 970 664 $ | 31/05/2026 |
Donald Wuchterl active positions
| Companies | Position | Start |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 19/04/2021 |
Former positions of Donald Wuchterl
| Companies | Position | End |
|---|---|---|
T-Knife Therapeutics, Inc.
 T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Corporate Officer/Principal | 01/08/2022 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Chief Operating Officer | 01/01/2016 |
Training of Donald Wuchterl
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Health Technology |
Colorado Technical University, Inc.
 Colorado Technical University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fitchburg State University
 Fitchburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
T-Knife Therapeutics, Inc.
T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Health Technology |
- Stock Market
- Insiders
- Donald Wuchterl
Choose MarketScreener 
